• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7
2
2
1
1

COUNTRY

1
1
1

CATEGORIES

  • 9
  • 2
  • 1
  • 1
  • 1

PRICE

0
0
1
12

PUBLISHED

0
0
2
12

PRODUCT TYPE

12

Search "Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011 " returned 12 results.

PRODUCT TITLE
Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report - Product Thumbnail Image Special Offer Sale Banner

Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report

TechNavio's analysts have conducted a survey on Impact of Patent Expiration on Key Drugs Categories for 2012-2016. The survey assessed the Impact of Patent Expiration on several key drugs categories...

November 2012
FROM
Pharmaceuticals - Global Outlook Pharmaceuticals - Global Outlook - Product Thumbnail Image

Pharmaceuticals - Global Outlook

The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings Punctuated with 46 statistically rich tables, the...

January 2012
FROM
Global Biopharma Outlook 2011: Major US and EU Global Biopharma Outlook 2011: Major US and EU - Product Thumbnail Image

Global Biopharma Outlook 2011: Major US and EU

The year 2011 and 2012 will be a bonanza for generic companies, as large innovator companies will lose patent exclusivity on prescription drugs worth over $70b in sales It is imperative to understand...

February 2011
FROM

Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management

GBI Research, the leading business intelligence provider, has released its latest research, “Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough...

May 2012
FROM
Global Biopharma Outlook 2011 Global Biopharma Outlook 2011 - Product Thumbnail Image

Global Biopharma Outlook 2011

Global Pharmaceutical and Biotechnology Outlook 2011 is an extensive, yet conclusive research work that encompasses a comprehensive, historical and forward looking analysis of 80 small and large cap...

January 2011
FROM
Hormone Replacement Therapy (HRT) - Global Strategic Business Report Hormone Replacement Therapy (HRT) - Global Strategic Business Report - Product Thumbnail Image

Hormone Replacement Therapy (HRT) - Global Strategic Business Report

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America,...

January 2014
FROM

Healthcare, Regulatory and Reimbursement Landscape - Sweden

Healthcare, Regulatory and Reimbursement Landscape - Sweden Summary GlobalData, the industry analysis specialist, has released its new report “Healthcare, Regulatory and Reimbursement Landscape -...

March 2013
FROM
Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma - Product Thumbnail Image

Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma

2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations The authors find these...

January 2014
FROM

Global Infertility Market 2015-2019

About Infertility Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility...

February 2015
FROM

Water for Pharmaceuticals: Opportunities in the developed and emerging markets

The pharmaceutical industry is suffering a period of uncertainty in the wake of the patent cliff in 2011. The days of double digit growth for Big Pharma are over as several blockbuster drugs expire...

July 2014

OpportunityAnalyzer: Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Summary The acute ischemic stroke (AIS) market is poised for major changes during the forecast window out to...

December 2013
FROM
Market Access Collection Market Access Collection - Product Thumbnail Image

Market Access Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.